Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer

NCT01355562 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Primary Investigator is no longer employed at LLU as of 02/29/12.

Conditions

Melanoma
Metastatic Kidney Cancer

Interventions

DRUG: Interleukin-2 (IL-2)

Sponsor

Loma Linda University